No valuation for Medtronic Paceart Optima System is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised and the funding record below are the closest available signals.
- ·Watch Medtronic Paceart Optima System: the Monday email on marks, rounds and moves
Funding history
No funding rounds for Medtronic Paceart Optima System are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
How Medtronic Paceart Optima System's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Medtronic Paceart Optima System, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by institutional fund marks. Question about this number? Full methodology →